Past and future of anabolic agents.
Ringe
J D
JD
Medizin Klinik 4, Klinikum Leverkusen (University of Cologne), D - 51375 Leverkusen (Germany).
D000818:Animals; D002118:Calcium / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005459:Fluorides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D050723:Fractures, Bone / Q000517:prevention & control; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D010281:Parathyroid Hormone / Q000627:therapeutic use*; D010710:Phosphates / Q000008:administration & dosage / Q000627:therapeutic use; D051381:Rats; D012189:Retrospective Studies; D012969:Sodium Fluoride / Q000627:therapeutic use; D016103:Spinal Fractures / Q000517:prevention & control; D013324:Strontium / Q000627:therapeutic use*; D013997:Time Factors
D010281:Parathyroid Hormone; D010710:Phosphates; D019382:Human Growth Hormone; C012980:fluorophosphate; D007334:Insulin-Like Growth Factor I; D012969:Sodium Fluoride; D005459:Fluorides; D002118:Calcium; D013324:Strontium